Special Issue "A Themed Issue in Honor of Professor Jordi Rello—Outstanding Contributions in the Fields of Management of Severe Infections and Sepsis"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 25279
Interests: antibiotic administration (particularly pharmacokinetics); pharmacodynamics; clinical trials
Special Issues, Collections and Topics in MDPI journals
Special Issue in Antibiotics: Feature Paper in Antibiotics for 2019
Special Issue in Antibiotics: Antibiotic Usage in Acute Situations
This Special Issue will honor Prof. Dr. Jordi Rello for his outstanding contributions in the fields of management of severe infections and sepsis. Prof Rello earned with honours his Medical Degree (1985) and PhD in Infectious Diseases (1990) at University of Barcelona, Spain, completing a residence/fellowship in Critical Care in Hospital Sant Pau in Barcelona. Dr Rello received additional training in infection control and ID epidemiology at Harvard Medical School, Boston. Currently, he is Director of the Clinical Research and Innovation in Pneumonia and Sepsis (CRIPS) Group at Vall d'Hebron Research Institute and CIBERES: http://www.vhir.org/gr/crips, located in Vall d’Hebron Barcelona Hospital Campus.
He has conducted clinical practice as a consultant, led research, and trained fellows in critical care and severe infections since 1990, with special focus on severe pneumonia and precision medicine in sepsis. He has served as medical advisor for Biopharma, led in the formation of several international clinical practices’ guidelines, and coordinated multidisciplinary groups on evidence-based medicine. After serving as critical care consultant in Hospital Clinic de Barcelona and Hospital Parc Tauli in Sabadell, Dr Rello became Head of the ICU Department in 1999 in the University Hospital de Tarragona and in 2000 at the University Hospital Vall d’Hebron, Barcelona. He is also a research advisor at the CHRU of Nîmes, France.
He has directed over 20 doctoral theses as part of his academic duties as Professor of Medicine at the Universitat Autònoma de Barcelona and Rovira and Virgili University in Tarragona. Currently, he is Chairman of Medicine at Universitat Internacional de Catalunya, Barcelona, Spain. He is an active member of the European Respiratory Society (FERS), and he also founded the Critically Ill Patients Working Groups at the European Society of Intensive Care Medicine where he served as Chair; he has been Deputy of the Infection Section at the European Society of Intensive Care medicine, and a council member as a representative of the Research and Scientific Committees. He has been President of the Catalonian Society of Critical Care and Secretary of the Catalonian Society of Infectious Diseases.
He has served as editor of multiple books, including the Textbook of Infections in Critically ill Patients and the Book Series Perspectives in Severe Infections in the ICU. He has served in many Editorial Boards, serving as associate editor at the European Journal of Infectious Diseases, BMC Infectious Diseases, and Anesthesia, Critical Care & Pain Medicine. He is a member of the Réanimation Committee at the Societé Française of Anesthesiologie et Réanimation (SFAR)
Prof. Rello has 630+ indexed manuscripts with 48,000+ citations (overall 2,850 per year since 2013), an H-index of 114 (64 since 2016) and i-10 index of 453 (340 since 2016)— accessed via Google Scholar. He has written 35+ papers with over 250 citations. He has been awarded as an international honorary professor of CSCCM—Chinese Medical Association (2018), and Fellow from the European Respiratory Society (2020), as well as the Young investigator Award from the American College of Chest Physicians, Award to the best year article of the year award from the Infectious Diseases Society of America, Annual Cardiovascular Specialty Award from the Society of critical Care Medicine, and Young Investigator University Award from Generalitat de Catalunya, among others.
Prof. Dr. Jeffrey Lipman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.